Terminated PHASE3 INTERVENTIONAL NCT00224692

Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine

MK III Trial: Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Cancer Mucositis

Interventions Low dose ketamine

Updated 5 times since 2017 Last updated: Oct 25, 2006 Started: Feb 28, 2003 Completion: Aug 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Assistance Publique - Hôpitaux de Paris

See all terminations from Assistance Publique - Hôpitaux de Paris

Other Cancer trials with similar outcome

Browse all Cancer trials

A PHASE3 clinical study on Cancer and Mucositis, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 5 data snapshots since 2003. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Feb 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France